Management Comment
“We are pleased to announce OVA1 expansion in our home state with a leading PPO network provider,” said Valerie Palmieri, President and CEO of Vermillion, Inc. “ Our technology helps define appropriate physician carepathways upfront which may have an impact on healthcare efficiencies, early detection and the likelihood of the right treatment for each individual patient. This is the second agreement we have reached in July 2016 as part of our overall campaign to pursue managed care coverage agreements throughout 2016. This agreement advances our plan to continue to expand OVA1 test adoption, further build our data repository and expand our clinical studies to demonstrate the ‘total cost of care’ benefit of OVA1 to healthcare systems.”